Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer
Clinical trial NCT01325207 · COMPLETED
Trial details
- NCT number
- NCT01325207
- Sponsor
- Northwestern University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2016-06-20
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.